Vijaya Diagnostic Centre Limited has informed the Exchange regarding Change in Auditors of the company.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre's board, at its July 28, 2025 meeting, approved the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025), along with limited review reports. The board also granted 2,500 Employee Stock Options under the VDCL ESOP Plan 2018 to support function employees (Finance, IT, Strategy, Operations), at an exercise price of ₹780 per share — set at a 20% discount to the 3-month average closing price. The options vest over three years (25%, 25%, 50%) with a 10-year exercise window. Additionally, the board appointed M/s. Balaramakrishna & Associates as Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30), subject to shareholder approval.
The ESOP grant is small (2,500 shares) and unlikely to materially affect shareholding or dilution. The appointment of a new secretarial auditor is a routine governance action and not indicative of any concerns. Overall, this is a standard quarterly compliance update with no negative signals for shareholders.